Companies in the Technology sector have received a lot of coverage today as analysts weigh in on Novanta (NOVT – Research Report) and Health Catalyst (HCAT – Research Report).
Novanta (NOVT)
Berenberg Bank analyst Andrew Buscaglia maintained a Hold rating on Novanta yesterday and set a price target of $130.00. The company’s shares closed last Monday at $155.87.
According to TipRanks.com, Buscaglia is ranked #6942 out of 8113 analysts.
Novanta has an analyst consensus of Hold, with a price target consensus of $130.00.
See today’s best-performing stocks on TipRanks >>
Health Catalyst (HCAT)
In a report released yesterday, Dev Weerasuriya from Berenberg Bank maintained a Buy rating on Health Catalyst, with a price target of $12.00. The company’s shares closed last Monday at $9.82, close to its 52-week low of $6.40.
According to TipRanks.com, Weerasuriya is a 1-star analyst with an average return of
Health Catalyst has an analyst consensus of Moderate Buy, with a price target consensus of $12.89, a 23.0% upside from current levels. In a report issued on November 8, BTIG also maintained a Buy rating on the stock with a $17.00 price target.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Read More on NOVT:
- Analysts Offer Insights on Consumer Goods Companies: Advance Auto Parts (AAP), Kellogg (K) and Canadian Tire (OtherCDNAF)
- LULU vs. ATZAF vs. LEVI: 3 Hot Apparel Stocks Analysts Love
- Univar (UNVR) Gets a Buy from Berenberg Bank
- Berenberg Bank Keeps Their Buy Rating on Qiagen (QGEN)
- Analysts Offer Insights on Services Companies: Cineplex (OtherCPXGF), Endeavor Group Holdings Inc (EDR) and Tremor International (TRMR)
